10May/13

Lilly Halts Drug Development After Failed Trial – Inside INdiana Business (press release)


Dividend.com

Lilly Halts Drug Development After Failed Trial
Inside INdiana Business (press release)
The study failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of relapse following rituximab-based chemotherapy. There were no new safety findings, and the safety data were …
Lilly To Take $30M Charge After Relapse Cancer Drug Disappoints in TrialFox Business
Enzastaurin, Eli Lilly’s Lymphoma Drug Fails In Late-Stage TrialMedical Daily
Lilly Halts Development of Lymphoma Drug After Phase III FailureGenetic Engineering News

all 15 news articles »

10May/13

Geisinger Partners with Indivumed for Personalized Medicine Initiative – Newswise – Newswise (press release)

Geisinger Partners with Indivumed for Personalized Medicine Initiative – Newswise
Newswise (press release)
Indivumed follows highly standardized processes that enable the company to limit cold ischemia time – the time between removal of tissue from the body and the time it is preserved – to less than 10 minutes, guaranteeing tissue samples maintain their …

and more »

10May/13

National agency on organ transplant ready – Zee News – Zee News

National agency on organ transplant ready – Zee News
Zee News
The amended act allows organ donations from a “near relative”, which it defines as spouse, son, daughter, father, mother, brother or sister. The amended law broadens the definition of “near relative” to include grandparents, grandchildren, uncles and …
CGHS likely to lower angioplasty ratesHindustan Times

all 3 news articles »